Olema Pharmaceuticals
OLMA
OLMA
97 hedge funds and large institutions have $584M invested in Olema Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 35 increasing their positions, 31 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
25.11% more ownership
Funds ownership: 89.34% → 114.44% (+25%)
13% more repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 31
11% more funds holding
Funds holding: 87 → 97 (+10)
Holders
97
Holding in Top 10
5
Calls
$2.91M
Puts
$534K
Top Buyers
| 1 | +$50.3M | |
| 2 | +$23.8M | |
| 3 | +$18.8M | |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$17.6M |
| 5 |
MB
MPM BioImpact
Boston,
Massachusetts
|
+$17.2M |
Top Sellers
| 1 | -$13.2M | |
| 2 | -$2.89M | |
| 3 | -$2.6M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$2.44M |
| 5 |
ACM
Aquilo Capital Management
San Francisco,
California
|
-$1.99M |